These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 23206928)
1. M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles. Herwig MC; Bergstrom C; Wells JR; Höller T; Grossniklaus HE Exp Eye Res; 2013 Feb; 107():52-8. PubMed ID: 23206928 [TBL] [Abstract][Full Text] [Related]
2. Detection of M2-macrophages in uveal melanoma and relation with survival. Bronkhorst IH; Ly LV; Jordanova ES; Vrolijk J; Versluis M; Luyten GP; Jager MJ Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):643-50. PubMed ID: 20811059 [TBL] [Abstract][Full Text] [Related]
3. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma. Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992 [TBL] [Abstract][Full Text] [Related]
4. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium? Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306 [TBL] [Abstract][Full Text] [Related]
5. The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma. Salmi S; Siiskonen H; Sironen R; Tyynelä-Korhonen K; Hirschovits-Gerz B; Valkonen M; Auvinen P; Pasonen-Seppänen S Melanoma Res; 2019 Jun; 29(3):237-247. PubMed ID: 30399061 [TBL] [Abstract][Full Text] [Related]
6. Association between gene expression profile, proliferation and metastasis in uveal melanoma. Onken MD; Worley LA; Harbour JW Curr Eye Res; 2010 Sep; 35(9):857-63. PubMed ID: 20795869 [TBL] [Abstract][Full Text] [Related]
7. Distribution and presumed proliferation of macrophages in inflammatory diseases of the ocular adnexae. Herwig MC; Holz FG; Loeffler KU Curr Eye Res; 2015 May; 40(6):604-10. PubMed ID: 25111002 [TBL] [Abstract][Full Text] [Related]
8. Evidence of macrophage and lymphocyte, but not dendritic cell, infiltration in posterior uveal melanomas, whilst cultured uveal melanomas demonstrate pluripotency by expressing CD68 and CD163. Woodward J; Sisley K; Reeves G; Nichols C; Parsons MA; Mudhar H; Rennie I Int J Exp Pathol; 2004 Feb; 85(1):35-43. PubMed ID: 15113392 [TBL] [Abstract][Full Text] [Related]
9. Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer. Lan C; Huang X; Lin S; Huang H; Cai Q; Wan T; Lu J; Liu J Technol Cancer Res Treat; 2013 Jun; 12(3):259-67. PubMed ID: 23289476 [TBL] [Abstract][Full Text] [Related]
10. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type. Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742 [TBL] [Abstract][Full Text] [Related]
11. Knockout of E2F1 enhances the polarization of M2 phenotype macrophages to accelerate the wound healing process. Xiao H; Wu YP; Yang CC; Yi Z; Zeng N; Xu Y; Zeng H; Deng P; Zhang Q; Wu M Kaohsiung J Med Sci; 2020 Sep; 36(9):692-698. PubMed ID: 32349192 [TBL] [Abstract][Full Text] [Related]
12. Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension? Heindl LM; Hofmann TN; Adler W; Knorr HL; Holbach LM; Naumann GO; Kruse FE; Cursiefen C Ophthalmology; 2010 Feb; 117(2):334-42. PubMed ID: 19892405 [TBL] [Abstract][Full Text] [Related]
13. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure. Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833 [TBL] [Abstract][Full Text] [Related]
14. Microcirculation and tumor-infiltrating macrophages in choroidal and ciliary body melanoma and corresponding metastases. Toivonen P; Mäkitie T; Kujala E; Kivelä T Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):1-6. PubMed ID: 14691146 [TBL] [Abstract][Full Text] [Related]
15. Digital PCR-Based T-cell Quantification-Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma. de Lange MJ; Nell RJ; Lalai RN; Versluis M; Jordanova ES; Luyten GPM; Jager MJ; van der Burg SH; Zoutman WH; van Hall T; van der Velden PA Mol Cancer Res; 2018 Dec; 16(12):1902-1911. PubMed ID: 30093564 [TBL] [Abstract][Full Text] [Related]
16. Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma. Bronkhorst IH; Vu TH; Jordanova ES; Luyten GP; Burg SH; Jager MJ Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5370-8. PubMed ID: 22743317 [TBL] [Abstract][Full Text] [Related]
17. Impact of macrophages on tumor growth characteristics in a murine ocular tumor model. Stei MM; Loeffler KU; Kurts C; Hoeller T; Pfarrer C; Holz FG; Herwig-Carl MC Exp Eye Res; 2016 Oct; 151():9-18. PubMed ID: 27426931 [TBL] [Abstract][Full Text] [Related]
18. Differential association of CD68 Tremble LF; McCabe M; Walker SP; McCarthy S; Tynan RF; Beecher S; Werner R; Clover AJP; Power XDG; Forde PF; Heffron CCBB Br J Cancer; 2020 Nov; 123(10):1553-1561. PubMed ID: 32843682 [TBL] [Abstract][Full Text] [Related]
19. Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderly. Poles WA; Nishi EE; de Oliveira MB; Eugênio AIP; de Andrade TA; Campos AHFM; de Campos RR; Vassallo J; Alves AC; Scapulatempo Neto C; Paes RAP; Landman G; Zerbini MCN; Colleoni GWB Cancer Immunol Immunother; 2019 Feb; 68(2):269-282. PubMed ID: 30430204 [TBL] [Abstract][Full Text] [Related]
20. Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer. Jackute J; Zemaitis M; Pranys D; Sitkauskiene B; Miliauskas S; Vaitkiene S; Sakalauskas R BMC Immunol; 2018 Jan; 19(1):3. PubMed ID: 29361917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]